Stigmasterol Inhibits Glioma Metastasis and Angiogenesis by Regulating Macrophage Polarization
Chemical Biology & Drug Design · 2026
DOI: 10.1111/cbdd.70249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2026. Verfasst von Xiangying Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Central South University Xiangya School of Medicine Affiliated Haikou Hospital/Haikou People's Hospital, Haikou, Hainan, P. …. Hauptthemen laut MEDLINE: Glioma, Stigmasterol, Macrophages, Neovascularization, Pathologic. Die Arbeit nennt 38 Literaturangaben. Gefördert von: High-level Talent Program of Natural Science Foundation of Hainan Province, The Natural Science Foundation of Hainan Province, Project of Health and Family Planning Commission of Hainan Province.
Abstract (Originalsprache)
Stigmasterol exhibits broad‐spectrum anticancer effects, but whether it exerts anti‐glioma effects through modulation of macrophage polarization remains unclear. Mouse bone marrow‐derived macrophages (BMDMs) were isolated and induced to polarize into M1 and M2 macrophages to obtain conditioned media (CM). GL261 cells were treated with CM and stigmasterol to evaluate their effects on cell function. Murine subcutaneous and metastatic tumor models were established. Cell viability, angiogenesis, migration, and invasion capacities were assessed using Cell Counting Kit‐8, tube formation, wound healing, and Transwell assays, respectively. Reverse transcription‐quantitative polymerase chain reaction, immunoblotting, immunofluorescence, and immunohistochemical staining were employed to measure mRNA and protein expression levels. Macrophage polarization was analyzed by flow cytometry. The results showed that stigmasterol inhibited glioma growth both in vitro and in vivo and reduced angiogenesis in HUVECs. Moreover, stigmasterol blocked the M2 macrophage‐mediated promotion of glioma growth and angiogenesis in HUVECs. The expression of metastasis‐related proteins and angiogenic factors in glioma cells induced by M2 macrophages was inhibited by stigmasterol treatment. Furthermore, stigmasterol attenuated macrophage polarization and restrained glioma formation and metastasis in vivo. This study shows that stigmasterol can suppress M2 macrophage polarization to inhibit the progression of gliomas, providing a potential therapeutic compound for glioma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Central South University Xiangya School of Medicine Affiliated Haikou Hospital/Haikou People's Hospital, Haikou, Hainan, P. R. China.
- Emergency Department, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, P. R. China.
- Department of Gastrointestinal Surgical Oncology, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, P. R. China.
- School of Life Sciences and Pharmacy, Hainan University, Haikou, Hainan, P. R. China.
ORCID-Profile: Qizhou Liang
Förderung
- High-level Talent Program of Natural Science Foundation of Hainan Province
- The Natural Science Foundation of Hainan Province
- Project of Health and Family Planning Commission of Hainan Province
- Natural Science Foundation of Hainan Province
Zitieren
APA
Li, X., Huang, D., Wang, D., Yuan, Y., Liu, L., Liu, H., & Liang, Q. (2026). Stigmasterol Inhibits Glioma Metastasis and Angiogenesis by Regulating Macrophage Polarization. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70249
Vancouver
Li X, Huang D, Wang D, Yuan Y, Liu L, Liu H, et al. Stigmasterol Inhibits Glioma Metastasis and Angiogenesis by Regulating Macrophage Polarization. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70249
BibTeX
@article{Li2026,
author = {Li, Xiangying and Huang, Danni and Wang, Danfeng and Yuan, Yuan and Liu, Lijie and Liu, Haiqing and Liang, Qizhou},
title = {Stigmasterol Inhibits Glioma Metastasis and Angiogenesis by Regulating Macrophage Polarization},
journal = {Chemical Biology & Drug Design},
year = {2026},
doi = {10.1111/cbdd.70249}
}
EUVIMED